** Shares of London-listed drugmaker Indivior INDV.L fall as much as 4.6% to 906.5p
** Company says its finance chief Ryan Preblick will step down as director as the group makes changes to its board following pressure from No. 2 shareholder Oaktree Capital
** INDV appoints Robert Schriesheim and Joe Ciaffoni as independent non-executive directors
** Says it has agreed to move towards a more standard U.S. system of remuneration for directors following its recent primary listing in New York
** "Fixing Indivior is not going to happen overnight and Oaktree's minor victory might simply be the first step in a complicated repair job" - AJ Bell
** Currently, stock down 3.4%, taking YTD losses to ~23%
(Reporting by Aby Jose Koilparambil in Bengaluru)
((abyjose.koilparambil@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。